The UAE’s focus on innovation is helping it to discover a lot of growing talent in the region, said Dr Ruchi Dana, a qualified medical practitioner, who has transitioned successfully into a seasoned entrepreneur and business leader.
Dana was recently invited by the Ministry of Economy for the Golden Visa for ‘Talented Individuals’, a special category for Golden Visa. “The Golden Visa initiative is a very good gesture by the UAE government to promote and retain talent in the region. I am extremely grateful to the UAE government for granting me the Golden Visa and I am looking forward to collaborating with authorities and universities for more research work in the region,” said Dana, who is a medical physician and a Stanford MBA.
“I also took the Stanford BioDesign programme and a lot of medical device companies are incubated and started from that programme. On similar lines, I hope to help commercialise medical devices, R&D Projects that come out of the universities in the UAE and help the nation be self-sufficient to emerge as a leader in industry 4.0 adoption.”
Dana is a frequent speaker at various industry conferences in the US, Europe, Middle East, India and South Asia and serves on several corporate and startup boards including Dana Group of Companies, UAE, Duluth Medical Technologies Inc US, University of California Chico Cybersecurity Board, American University Dubai (AUD) Entrepreneurship and Innovation Center AEIC-UI.
Dana, who is also an advisor to some Silicon Valley-based VC firms and has been recognised by Forbes Middle East as ‘Next Gen Business Leader, Arab World’ and Forbes ME Top PowerBusinesswomen 2020. “I look forward to creating a bridge between the Silicon Valley and the Middle East and help play my part in UAE’s vision for industrial growth. I strive to contribute to the realisation of the UAE’s ‘Operation 300 Bn’ to transform the industrial and advanced technology sector and promote the ‘Make It in the Emirates’ initiative of the government,” added Dana.
Dana has been working on medical devices right through her undergraduate college days and has presented various papers, publications on low-cost medical devices at international conferences. Following her passion for medical devices, she is currently also devoting time to Duluth Medical Technologies, a Silicon Valley-based Robotic Medtech company, as President, COO and is looking to realise her dream of making robotic surgeries more affordable and scalable, thus democratising healthcare for all.
Duluth has filed several US patents for its IP, and Dana is one of the inventors of these US PCT patents. Dana was invited by the UAE’s Prime Minister’s Office to present a case study on Duluth for the UAE Government Youth Leaders Programme 2021. — sandhya@khaleejtimes.com
The growth in the profit by Dh62.01 million attributed to the continued strong performance of the group’s manufacturing, contracting and services segment
Second quarter net operating income of Dh6 million compared to Dh24 million in Q1 2022 mainly due to lower trading revenues; Net loss attributable to shareholders of Dh170 million in Q2 2022 compared to net income of Dh6 million in Q1 2022
The UAE, the company’s largest market, saw high growth in merchant payments processed from domestic consumers at 20 per cent year on year, and payments from international visitors growing 92 per cent
The company's strong balance sheet will support the company’s growth strategy, including investments in digital and technological infrastructure as well as its active merger and acquisition pipeline
The company’s revenue increased 31 per cent to Dh1.041 billion as compared to Dh792 million in first half of 2021 while its operating costs dropped 16 per cent
Kashkari sticks to his view of 3.9% Fed funds rate at end-2022; Evans sees 3.4% policy rate this year; Both push back on market expectation for rate cuts next year; Inflation, employment data to determine size of Sept rate hike
Approval would save time, money on Asian routes; Q2 net profit $100m versus loss of $81m a year ago; Revenue up sharply, but still below Q2 in 2019